Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$154.64 USD
+0.36 (0.23%)
Updated May 17, 2024 04:00 PM ET
After-Market: $155.00 +0.36 (0.23%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Brokerage Reports
Johnson & Johnson [JNJ]
Reports for Purchase
Showing records 421 - 440 ( 499 total )
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Worldwide Orthopedics Market
Provider: G.RESEARCH, LLC
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Consumer Unit Holds Back Overall Growth, but New Drugs and Acquisitions Contributed
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
LIFE SCIENCES-The Week Ahead in Life Sciences - Upcoming Events for the Week of January 20
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
LIFE SCIENCES - The Week Ahead in Life Sciences - Upcoming Events for the Week of December 23
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Strong U.S. Pharmaceutical Results Boost Third Quarter Revenue.
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Managed Higher EPS Despite a More Severe Drag from Currency and Weakness in Some Areas
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S